Literature DB >> 20674805

Antiviral drug resistance: mechanisms and clinical implications.

Lynne Strasfeld1, Sunwen Chou.   

Abstract

Antiviral drug resistance is an increasing concern in immunocompromised patient populations, where ongoing viral replication and prolonged drug exposure lead to the selection of resistant strains. Rapid diagnosis of resistance can be made by associating characteristic viral mutations with resistance to various drugs as determined by phenotypic assays. Management of drug resistance includes optimization of host factors and drug delivery, selection of alternative therapies based on knowledge of mechanisms of resistance, and the development of new antivirals. This article discusses drug resistance in herpesviruses and hepatitis B. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20674805     DOI: 10.1016/j.idc.2010.07.001

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  21 in total

Review 1.  Progress in the development of new therapies for herpesvirus infections.

Authors:  Nathan B Price; Mark N Prichard
Journal:  Curr Opin Virol       Date:  2011-12       Impact factor: 7.090

2.  A chronicle of SARS-CoV-2: Seasonality, environmental fate, transport, inactivation, and antiviral drug resistance.

Authors:  Manish Kumar; Payal Mazumder; Sanjeeb Mohapatra; Alok Kumar Thakur; Kiran Dhangar; Kaling Taki; Santanu Mukherjee; Arbind Kumar Patel; Prosun Bhattacharya; Pranab Mohapatra; Jörg Rinklebe; Masaaki Kitajima; Faisal I Hai; Anwar Khursheed; Hiroaki Furumai; Christian Sonne; Keisuke Kuroda
Journal:  J Hazard Mater       Date:  2020-10-06       Impact factor: 10.588

3.  Efficacy of Tilorone Dihydrochloride against Ebola Virus Infection.

Authors:  Sean Ekins; Mary A Lingerfelt; Jason E Comer; Alexander N Freiberg; Jon C Mirsalis; Kathleen O'Loughlin; Anush Harutyunyan; Claire McFarlane; Carol E Green; Peter B Madrid
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

4.  Different Variants in Reverse Transcriptase Domain Determined by Ultra-deep Sequencing in Treatment-naïve and Treated Indonesian Patients Infected with Hepatitis B Virus.

Authors:  Widya Wasityastuti; Yoshihiko Yano; Dewiyani Indah Widasari; Laura Navika Yamani; Neneng Ratnasari; Didik Setyo Heriyanto; Rina Okada; Toshihito Tanahashi; Yoshiki Murakami; Takeshi Azuma; Yoshitake Hayashi
Journal:  Kobe J Med Sci       Date:  2016-06-16

5.  Asymmetric total synthesis of (+)- and (-)-clusianone and (+)- and (-)-clusianone methyl enol ether via ACC alkylation and evaluation of their anti-HIV activity.

Authors:  Michelle R Garnsey; James A Matous; Jesse J Kwiek; Don M Coltart
Journal:  Bioorg Med Chem Lett       Date:  2011-02-23       Impact factor: 2.823

6.  Broad-spectrum non-nucleoside inhibitors of human herpesviruses.

Authors:  Lora McClain; Yun Zhi; Hoyee Cheng; Ayantika Ghosh; Paolo Piazza; Michael B Yee; Santosh Kumar; Jadranka Milosevic; David C Bloom; Ravit Arav-Boger; Paul R Kinchington; Robert Yolken; Vishwajit Nimgaonkar; Leonardo D'Aiuto
Journal:  Antiviral Res       Date:  2015-06-12       Impact factor: 5.970

Review 7.  New Perspectives on Antimicrobial Agents: Maribavir.

Authors:  Virginie Halpern-Cohen; Emily A Blumberg
Journal:  Antimicrob Agents Chemother       Date:  2022-08-02       Impact factor: 5.938

8.  Deciphering Complex Mechanisms of Resistance and Loss of Potency through Coupled Molecular Dynamics and Machine Learning.

Authors:  Florian Leidner; Nese Kurt Yilmaz; Celia A Schiffer
Journal:  J Chem Theory Comput       Date:  2021-03-30       Impact factor: 6.006

Review 9.  Naturally occurring hepatitis B virus reverse transcriptase mutations related to potential antiviral drug resistance and liver disease progression.

Authors:  Yu-Min Choi; So-Young Lee; Bum-Joon Kim
Journal:  World J Gastroenterol       Date:  2018-04-28       Impact factor: 5.742

Review 10.  Antiviral potential of natural products from marine microbes.

Authors:  Mengqi Yi; Sixiao Lin; Bin Zhang; Haixiao Jin; Lijian Ding
Journal:  Eur J Med Chem       Date:  2020-08-31       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.